Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors’ reply
2019 ◽
Vol 49
(8)
◽
pp. 1086-1087
◽
Keyword(s):
2020 ◽
Vol 55
(5)
◽
pp. 560-564
Keyword(s):
2019 ◽
Vol 53
(9)
◽
pp. 660-672
◽